European market entry for healthcare and MedTech companies
Entering Europe requires more than finding a distributor. It requires commercial focus, local credibility, market access understanding, operational readiness and the right partner structure.
Q22 helps international companies build a credible and executable route into Europe, from market selection and distributor setup to regulatory, quality, logistics, returns, repair and customer access.
Where Q22 helps
Q22 supports European expansion for companies that need practical commercial guidance and local execution capacity.
- European market selection and commercial entry strategy
- Distributor setup and commercial partner selection
- Market access support and stakeholder mapping
- Regulatory, quality and permit coordination through trusted partners
- Logistics, fulfillment, repair, returns and invoicing setup
- Business development and first customer conversations
Typical clients
International MedTech, pharma, health ingredient and healthcare companies that want to enter Europe without building everything alone from day one.
A practical route into Europe
Q22 combines strategy and execution, so the plan does not stop at advice. The focus is on what needs to happen next, who needs to be involved and which partners can make the launch realistic.
Focus
Define the right European markets, target customers, commercial proposition and launch priorities.
Setup
Build the right structure for partners, operations, regulatory support, quality processes and customer access.
Execution
Support outreach, partner discussions, customer conversations and commercial traction.
Let’s discuss your next move
For questions, introductions or a first discussion, please contact Q22 directly by email.
Q22
Senior commercial thinking, practical execution and access to the right partners across the healthcare value chain.